Novel mutations in MYTH4-FERM domains of myosin 15 are associated with autosomal recessive nonsyndromic hearing loss.


Journal

International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 22 09 2018
revised: 20 11 2018
accepted: 20 11 2018
pubmed: 24 12 2018
medline: 14 3 2019
entrez: 23 12 2018
Statut: ppublish

Résumé

Hereditary hearing loss is the most common neurosensory disorder in humans caused by myriad mutations in numerous genes. Autosomal recessive nonsyndromic hearing loss (ARNSHL) accounts for 80% of hearing impairments of genetic origin and is quite prevalent in societies with a high rate of consanguinity. In the current study, we investigated the causes of sensorineural hearing loss in 24 unrelated Iranian families who were mainly consanguineous and had at least two affected children. All probands were initially screened for GJB2 mutations, as the most common causes of ARNSHL in Iran. Verified GJB2-negative samples were subsequently subjected to whole exome sequencing (WES) to identify the underlying causes of hearing impairment, and the variants identified in each family were further confirmed by Sanger sequencing. WES revealed three previously unreported mutations in MYO15A, the gene encoding the unconventional myosin 15 (Myo15). All variants identified, c.C6436T (p.R2146W), c.C9584G (p.P3195R) and c.G10266C (p.Q3422H), reside in the MYTH4 (myosin tail homology) and FERM (4.1 ezrin, radixin, moesin) domains of the protein. Globally, mutations in MYO15A are considered to be among the most prevalent genetic causes of ARNSHL, and they rank as the third leading cause of hearing loss in the Iranian population, below GJB2 and SLC26A4. Yet again, these results endorse the importance of MYO15 screening in hearing impaired populations, particularly in Iran.

Identifiants

pubmed: 30579064
pii: S0165-5876(18)30587-1
doi: 10.1016/j.ijporl.2018.11.025
pii:
doi:

Substances chimiques

MYO15A protein, human 0
Myosins EC 3.6.4.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115-126

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Hoda Mehregan (H)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Marzieh Mohseni (M)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Khadijeh Jalalvand (K)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Sanaz Arzhangi (S)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Nooshin Nikzat (N)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Sussan Banihashemi (S)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Kimia Kahrizi (K)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Hossein Najmabadi (H)

Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. Electronic address: hnajm12@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH